Skip to main content
Current Health Sciences Journal logoLink to Current Health Sciences Journal
. 2020 Dec 31;46(4):329–335. doi: 10.12865/CHSJ.46.04.02

Developmental Abnormalities of the Skull Base in Patients with Turner Syndrome

ADINA-IOANA TECUTA-BUSOI 1, MARIUS MATEI 2, LUCIAN MIHAI FLORESCU 3, IOANA ANDREEA GHEONEA 3
PMCID: PMC7948014  PMID: 33717506

Abstract

The skull base is one of the most complex anatomic structures of the skeleton that is responsible for protecting and supporting the brain and is also involved in the development of the facial structures. The main objective of our study was to evaluate skull base abnormalities in a group of patients diagnosed with Turner syndrome by assessing lateral cephalometric radiographs. A total of 7 patients diagnosed with Turner syndrome in the Endocrinology Department of the Emergency Clinical County Hospital of Craiova were included in the study. The following cephalometric variables were measured in our study: total skull base (N-Ba): Nasion (N)-Basion (Ba); anterior skull base (N-S): Nasion (N)-Sella (S); posterior skull base (S-Ba): Sella (S)-Basion (Ba). Regarding the investigated cephalometric variables, the mean±standard deviation (SD) recorded values in our study were 86.34±4.26mm for the total skull base (N-Ba), 63.87±2.54mm for the anterior skull base (N-S) and 38.33±4.87mm for the posterior skull base (S-Ba). The results of our study were compared to the ones provided by one of the most representative studies described in the literature. A reduced size of the posterior base of the skull is considered pathognomonic in subjects diagnosed with Turner syndrome. Also, the posterior base of the skull directly influences the maxillomandibular skeletal relationships and it is therefore necessary to calculate this cephalometric variable, which is easily highlighted on a lateral cephalometric radiograph.

Keywords: Cephalometry, skull base, Turner syndrome

Introduction

The skull base is one of the most complex anatomic structures of the skeleton that is responsible for protecting and supporting the brain and is also involved in the development of the facial structures.

In the latter case, the anterior base of the skull plays a central role due to its direct connection to the upper and middle face [1].

The base of the skull has different embryological origins.

Therefore, the anterior skull base develops from the neural crest alone, in a similar manner to the facial bones, while the posterior skull base develops from the paraxial mesoderm [1,2,3].

The base of the skull is formed through encondral ossification, in opposition to the craniofacial bones which are developed through intramembranous ossification.

The connection between the brain and the morphogenesis of the skull base has been studied for a long period of time.

Given the current knowledge, it seems that in the initial phase, the development and growth of the skull base is regulated by the brain, but this process still remains to be completely understood [1,4,5,6,7,8,9,10].

The relationship between the base of the skull and the dento-facial complex is also extremely important, mainly because pathologic growth and/or abnormal orientation of the skull base can lead to an abnormal position of both mandible and jaw in addition to an impaired mobility of these anatomical structures.

All these aspects indicate that the skull base is a unique structure due to its anatomical complexity and embryological development [11,12,13,14,15,16,17,18,19,20,21,22].

Aim

The main objective of our study was to evaluate skull base abnormalities in a group of patients diagnosed with Turner syndrome by assessing lateral cephalometric radiographs.

Material and Methods

The current study received approval from the local Ethics Committee.

The attending physician and the legal relatives of all the patients included in the study freely expressed their consent regarding the use of medical data for research purposes.

A total of seven patients diagnosed with Turner syndrome in the Endocrinology Department of the Emergency Clinical County Hospital of Craiova were included in the study.

The lateral cephalometric radiographs were performed with the help of a Carestream CS 8100SC device using the standard patient positioning represented by the perpendicular orientation of the X-ray beam on the patient’s sagittal plane.

Measurements of different cephalometric variables were performed by a single investigator.

Given that we performed linear and angular measurements, the results were expressed in milimeters and degrees.

The statistical processing of the measurements involved calculating the mean and standard deviation values.

The cephalometric points and reference lines for linear and angular measurements were marked on the lateral cephalometric radiographs (Figures 1 and 2).

Figure 1.

Figure 1

Cephalometric points and reference lines used for linear measurements: Nasion (N), Sella (S), Basion (B), Pterygo-maxillary point (Pm), Gnathion (Gn), Gonion (Go).

Figure 2.

Figure 2

Labelled cephalometric points on a lateral cephalogram belonging to a male subject diagnosed with growth hormone deficiency: Nasion (N), Sella (S), Basion (B), Pterygo-maxillary point (Pm), Subspinale (Ss), Supramentale (Sm), Gnathion (Gn), Gonion (Go)

The cephalometric points identified on a lateral cephalometric radiograph include:

- Nasion (N)-the most anterior point corresponding to the fronto-nasal suture;

- Point A-the most posterior point on the anterior contour of the upper jaw;

- Point B-the most posterior point on the anterior contour of the mandibular body, on the midline;

- Sella (S)-the rearmost opposite point of the quadrilateral blade;

- Basion (Ba)-the foremost point of the foramen magnum.

The following cephalometric variables were measured in our study:

- total skull base (N-Ba): Nasion (N)-Basion (Ba);

- anterior skull base (N-S): Nasion (N)-Sella (S);

- posterior skull base (S-Ba): Sella (S)-Basion (Ba).

We used IBM SPSS Statistics (version 20) for statistical calculations and the One-Way Analysis of Variance (ANOVA) test, considering a p value below 0.05 as statistically significant.

Results

Regarding the investigated cephalometric variables, the mean±standard deviation (SD) recorded values in our study were 86.34±4.26mm for the total skull base (N-Ba), 63.87±2.54mm for the anterior skull base (N-S) and 38.33±4.87mm for the posterior skull base (S-Ba) (Table 1).

Table 1.

The mean and SD recorded values of the investigated cephalometric variables in our study

Variable

Mean

SD

Total skull base N-Ba (mm)

86.34

4.26

Anterior skull base N-S (mm)

63.87

2.54

Posterior skull base S-Ba (mm)

38.33

4.87

A comparison between our study and the one conducted by Dumancic regarding the mean and SD values of these parameters is illustrated in Table 2.

Table 2.

A comparison between the results of our study and the results presented by Dumancic [23]

Variable

The study performed by Dumancic

The current study

Mean

SD

Mean

SD

Total skull base N-Ba (mm)

93.07

6.01

86.34

4.26

Anterior skull base N-S (mm)

63.52

3.83

63.87

2.54

Posterior skull base S-Ba (mm)

36.90

3.11

38.33

4.87

The values of N-Ba ranged between 75.27mm and 104.92mm in our study.

Also, the values of N-S recorded in our study ranged between 54.90mm and 73.10mm, while the values of S-Ba ranged between 31.47mm and 49.22mm.

A comparison between our study and the one conducted by Dumancic regarding the minimum and maximum values of these parameters is illustrated in Table 3.

Table 3.

A comparison between the results of our study and the results obtained by Dumancic in the Turner syndrome group [23]

Variable

The study performed by Dumancic Turner syndrome group

The current study

Minimum

Maximum

Minimum

Maximum

Total skull base N-Ba (mm)

82.50

111.63

75.27

104.92

Anterior skull base N-S (mm)

55.38

72.58

54.90

73.10

Posterior skull base S-Ba (mm)

30.93

48.29

31.47

49.22

We obtained a significant difference between the mean value of N-Ba provided by our study and the one provided by Dumancic (p<0.05).

However, the results of our study did not indicate any statistically significant differences between: (i) the mean value of N-S recorded in our study and the one obtained by Dumancic (p=0.580); (ii) the mean value of S-Ba provided by our study and the one obtained by Dumancic (p=0.356).

In our study, the mean value of the total skull base variable was lower than the mean value of the same variable presented by Dumancic in his study.

However, the mean value of the posterior skull base variable was slightly higher in our study.

The mean values of the anterior skull base variable were similar between the two studies.

Discussions

In patients with Turner syndrome, the shortening of the posterior skull base occurs mainly due to the X chromosome deficiency in craniofacial development in intrauterine life and in early childhood [23,24,25,26,27].

However, the anterior base of the skull may present a normal development in patients diagnosed with Turner syndrome given that this segment enlarges with the pneumatization and thickening of the frontal bone.

This usually happens at the age of six after the spheno-ethmoidal synchondrosis is closed.

Therefore, the evaluation of the skull base on a lateral cephalometric radiograph is extremely important due to the fact that the total skull base (N-Ba) and posterior skull base (S-Ba) appear to be shorter than in the normal population [23,25,26,27,28,29,30,31,32,33].

Our study revealed similar values compared to the study conducted by Dumancic regarding the anterior skull base investigated variable.

The mean value of the total skull base was lower in our study group but the mean value of the posterior skull base was lower in the Dumancic study [23].

The reduction of the posterior skull base are characteristic elements for patients diagnosed with Turner syndrome.

A functional connection can be observed between the skull base and the dento-facial complex, a relationship that is decisive in both normal and pathological occlusion.

Thus, developmental abnormalities of the posterior base of the skull are related to the prognathism of the mandible, while changes in the anterior base of the skull are related to the retrusion of the jaw.

Currently, the spheno-ethmoidal complex is considered to be the main mechanism in the retrognation of the maxilla and mandible.

All these considerations demonstrate that the growth defects of the skull base are the main cause of facial retrognation [23,31,32,33,34,35].

The growth of the skull base is regulated by endocrine mechanisms.

Therefore, a growth hormone deficiency influences the skull base growth [24,36,37,38,39,40].

In patients with Turner syndrome, growth hormone replacement therapy greatly influences the growth of the mandible, but manifests only a minor effect on the base of the skull growth.

This is mainly due to the fact that at some point, both the mandible and the jaw still continue to grow while the skull base is completely developed [23,24,25,26,41,42].

Also, there are other pathologies that present abnormalities of the skull base: Down syndrome, craniosynostosis syndromes, cleido-cranial dysplasia etc.

In all these conditions, the skull base plays a central role in developing craniofacial abnormalities [43,44,45,46,47,48].

Recent studies indicate that growth hormone deficiency is associated with a reduced size of the skull base and face which results in malocclusions.

However, there seems to be no connection between craniofacial growth and teeth development.

Several studies evaluated the effects of growth hormone replacement therapy and most of the results indicated a difference in growth rate represented by a delayed development of the teeth compared to the craniofacial growth [49,50].

There are multiple dental pathological conditions secondary to growth hormone deficiency, which must be well documented and diagnosed.

After that, the most appropriate therapy is chosen in order to correct various pathological changes, some of which are related to growth hormone deficiency [51,52,53,54].

But the anomalies that appeared during the craniofacial growth and development process are not always caused by hormonal deficiencies, but can also be associated with genetic defects and low gestational weight [29,36,43,54].

All the previously mentioned aspects indicate the importance of the skull base in the facial growth and development.

Therefore, we consider the evaluation of the skull base and prognosis angles of the mandible and maxilla to be the most important cephalometric variables in highlighting craniofacial changes in patients diagnosed with

Turner syndrome, in order to establish a correct diagnosis and apply an orthodontic suitable strategy.

Cephalometry is the most appropriate method in diagnosing and monitoring deficiencies in craniofacial growth and development in children with growth hormone deficiency.

Conclusions

A reduced size of the posterior base of the skull is considered pathognomonic in subjects diagnosed with Turner syndrome.

Therefore, there is a functional connection between the skull base and the dento-facial complex.

Also, the posterior base of the skull directly influences the maxillomandibular skeletal relationships and it is therefore necessary to calculate this cephalometric variable, which is easily highlighted on a lateral cephalometric radiograph.

Conflict of interests

None to declare.

Acknowledgments

Acknowledgments

Adina-Ioana Tecuta-Busoi and Marius Matei contributed equally to the manuscript and thus share main authorship.

References

  • 1.Nie X. Cranial base in craniofacial development: Developmental features, influence on facial growth, anomaly, and molecular basis. Acta Odontologica Scandinavica. 2005;63(3):127–135. doi: 10.1080/00016350510019847. [DOI] [PubMed] [Google Scholar]
  • 2.Couly GF, Coltey PM, Le Douarin NM. The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development. 1993;117(2):409–429. doi: 10.1242/dev.117.2.409. [DOI] [PubMed] [Google Scholar]
  • 3.Le Douarin NM, Ziller C, Couly GF. Patterning of neural crest derivatives in the avian embryo: in vivo and in vitro studies. Dev Biol. 1993;159(1):24–49. doi: 10.1006/dbio.1993.1219. [DOI] [PubMed] [Google Scholar]
  • 4.Ross CF, Ravosa MJ. Basicranial flexion, relative brain size, and facial kyphosis in nonhuman primates. Am J Phys Anthropol. 1993;91(3):305–324. doi: 10.1002/ajpa.1330910306. [DOI] [PubMed] [Google Scholar]
  • 5.Lieberman DE, McCarthy RC. The ontogeny of cranial base angulation in humans and chimpanzees and its implications for reconstructing pharyngeal dimensions. J Hum Evol. 1999;36(5):487–517. doi: 10.1006/jhev.1998.0287. [DOI] [PubMed] [Google Scholar]
  • 6.Lieberman DE, Pearson OM, Mowbray KM. Basicranial influence on overall cranial shape. J Hum Evol. 2000;38(2):291–315. doi: 10.1006/jhev.1999.0335. [DOI] [PubMed] [Google Scholar]
  • 7.Ross C, Henneberg M. Basicranial flexion, relative brain size, and facial kyphosis in Homo sapiens and some fossil hominids. Am J Phys Anthropol. 1995;98(4):575–593. doi: 10.1002/ajpa.1330980413. [DOI] [PubMed] [Google Scholar]
  • 8.Jeffery N, Spoor F. Brain size and the human cranial base: a prenatal perspective. Am J Phys Anthropol. 2002;118(4):324–340. doi: 10.1002/ajpa.10040. [DOI] [PubMed] [Google Scholar]
  • 9.McCarthy RC. Anthropoid cranial base architecture and scaling relationships. J Hum Evol. 2001;40(1):41–66. doi: 10.1006/jhev.2000.0446. [DOI] [PubMed] [Google Scholar]
  • 10.Ross CF, Henneberg M, Ravosa MJ, Richard S. Curvilinear, geometric and phylogenetic modeling of basicranial flexion: is it adaptive, is it constrained. J Hum Evol. 2004;46(2):185–213. doi: 10.1016/j.jhevol.2003.11.001. [DOI] [PubMed] [Google Scholar]
  • 11.Bradley JP, Levine JP, Blewett C, Krummel T, McCarthy JG, Longaker MT. Studies in cranial suture biology:in vitro cranial suture fusion. Cleft Palate Craniofac J. 1996;33(2):150–156. doi: 10.1597/1545-1569_1996_033_0150_sicsbv_2.3.co_2. [DOI] [PubMed] [Google Scholar]
  • 12.Kim HJ, Rice DP, Kettunen PJ, Thesleff I. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development. 1998;125(7):1241–1251. doi: 10.1242/dev.125.7.1241. [DOI] [PubMed] [Google Scholar]
  • 13.Battagel JM. The aetiological factors in Class III malocclusion. Eur J Orthod. 1993;15(5):347–370. doi: 10.1093/ejo/15.5.347. [DOI] [PubMed] [Google Scholar]
  • 14.Dhopatkar A, Bhatia S, Rock P. An investigation into the relationship between the cranial base angle and malocclusion. Angle Orthod. 2002;72(5):456–463. doi: 10.1043/0003-3219(2002)072<0456:AIITRB>2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 15.Singh GD, McNamara JA, Lozanoff S. Morphometry of the cranial base in subjects with Class III malocclusion. J Dent Res. 1997;76(2):694–703. doi: 10.1177/00220345970760021101. [DOI] [PubMed] [Google Scholar]
  • 16.Anderson D, Popovich F. Relation of cranial base flexure to cranial form and mandibular position. Am J Phys Anthropol. 1983;61(2):181–187. doi: 10.1002/ajpa.1330610206. [DOI] [PubMed] [Google Scholar]
  • 17.Anderson DL, Popovich F. Lower cranial height vs craniofacial dimensions in Angle Class II malocclusion. Angle Orthod. 1983;53(3):253–260. doi: 10.1043/0003-3219(1983)053<0253:LCHVCD>2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 18.Hopkin GB, Houston WJ, James GA. The cranial base as an aetiological factor in malocclusion. Angle Orthod. 1968;38(3):250–255. doi: 10.1043/0003-3219(1968)038<0250:TCBAAA>2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 19.Singh GD. Morphologic determinants in the etiology of class III malocclusions: a review. Clin Anat. 1999;12(5):382–405. doi: 10.1002/(SICI)1098-2353(1999)12:5<382::AID-CA9>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  • 20.Singh GD, McNamara JA, Lozanoff S. Craniofacial heterogeneity of prepubertal Korean and European-American subjects with Class III malocclusions: procrustes, EDMA, and cephalometric analyses. Int J Adult Orthodon Orthognath Surg. 1998;13(3):227–240. [PubMed] [Google Scholar]
  • 21.Singh GD, McNamara JA, Lozanoff S. Allometry of the cranial base in prepubertal Korean subjects with class III malocclusions: finite element morphometry. Angle Orthod. 1999;69(6):507–514. doi: 10.1043/0003-3219(1999)069<0507:AOTCBI>2.3.CO;2. [DOI] [PubMed] [Google Scholar]
  • 22.Guyer EC, Ellis EE, McNamara JA, Behrents RG. Components of class III malocclusion in juveniles and adolescents. Angle Orthod. 1986;56(1):7–30. doi: 10.1043/0003-3219(1986)056<0007:COCIMI>2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 23.Dumancic J, Kaic Z, LapterVarga M, Lauc T, Dumic M, Anic Milosevic S, Brkic H. Characteristics of the craniofacial complex in Turner syndrome. Archives of oral biology. 2010;55(1):81–88. doi: 10.1016/j.archoralbio.2009.10.008. [DOI] [PubMed] [Google Scholar]
  • 24.Hass AD, Simmons KE, Davenport ML, Proffit WR. The effect of growth hormone on craniofacial growth and dental maturation in Turner syndrome. Angle Orthod. 2001;71(1):50–59. doi: 10.1043/0003-3219(2001)071<0050:TEOGHO>2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 25.Cazzolla AP, Lo Muzio L, Di Fede O, Lacarbonara V, Colaprico A, Testa NF, Giuseppe T, Zhurakivska K, Marzo G, Lacaita MG. Orthopedic-orthodontic treatment of the patient with Turner's syndrome: Review of the literature and case report. Spec Care Dentist. 2018;38(4):1–10. doi: 10.1111/scd.12295. [DOI] [PubMed] [Google Scholar]
  • 26.Juloski J, Glisic B, Scepan I, Milasin J, Mitrovic K, Babic M. Ontogenetic changes of craniofacial complex in Turner syndrome patients treated with growth hormone. Clin Oral Invest. 2013;17(6):1563–1571. doi: 10.1007/s00784-012-0844-8. [DOI] [PubMed] [Google Scholar]
  • 27.Bishara SE. In: Textbook of orthodontics 1st Edition. Bishara SE, editor. Philadelphia: Saunders; 2001. Growth and development; pp. 2–96. [Google Scholar]
  • 28.Jensen BL, Kreiborg S. Development of the skull in infants with cleidocranial dysplasia. J Craniofac Genet Dev Biol. 1993;13(2):89–97. [PubMed] [Google Scholar]
  • 29.Juloski J, Glisic B, Scepan I, Milasin J, Mitrovic K, Babic M. Ontogenetic changes of craniofacial complex in Turner syndrome patients treated with growth hormone. Clin Oral Invest. 2013;17(6):1563–1571. doi: 10.1007/s00784-012-0844-8. [DOI] [PubMed] [Google Scholar]
  • 30.Preda SA, Albulescu DM, Mitroi MR, Popescu M, Nechita F, Camen A, Cotoi IA. Craniofacial morphology aspects in children whit isolated growth hormone deficiency-a cephalometric study. Rom J Morphol Embryol. 2019;60(2):653–658. [PubMed] [Google Scholar]
  • 31.Midtbø M, Wisth PJ, Halse A. Craniofacial morphology in young patients with Turner syndrome. Eur J Orthod. 1996;18(3):215–225. doi: 10.1093/ejo/18.3.215. [DOI] [PubMed] [Google Scholar]
  • 32.Gron M, Pietila K, Alvesalo L. The craniofacial complex in 45,X/46,XX females. Arch Oral Biol. 1999;44(12):1077–1084. doi: 10.1016/s0003-9969(99)00088-6. [DOI] [PubMed] [Google Scholar]
  • 33.Perkiomaki MR, Kyrkanides S, Niinimaa A, Alvesalo L. The relationship of distinct craniofacial features between Turner syndrome females and their parents. Eur J Orthod. 2005;27(1):48–52. doi: 10.1093/ejo/cjh086. [DOI] [PubMed] [Google Scholar]
  • 34.Rongen-Westerlaken C, vd Born E, Prahl-Andersen B, Rikken B, Teunenbroek V, Kamminga N, vd Tweel I, Otten BJ, Delamarre vd Waal HA, Drayer NM. Shape of the craniofacial complex in children with Turner syndrome. J Biol Buccale. 1992;20(4):185–190. [PubMed] [Google Scholar]
  • 35.Babic M, Scepan I, Micic M. Comparative cephalometric analysis in patients with X-chromosome aneuploidy. Arch Oral Biol. 1993;38(2):179–183. doi: 10.1016/0003-9969(93)90204-y. [DOI] [PubMed] [Google Scholar]
  • 36.Choi SH, Fan D, Hwang MS, Lee HK, Hwang CJ. Effect of growth hormone treatment on craniofacial growth in children: Idiopathic short stature versus growth hormone deficiency. J Formos Med Assoc. 2017;116(4):313–321. doi: 10.1016/j.jfma.2016.05.011. [DOI] [PubMed] [Google Scholar]
  • 37.Cantu G, Buschang P, Gonzalez JL. Differential growth and maturation in idiopathic growth-hormone-deficient children. European Journal of Orthodontics. 1997;19(2):131–139. doi: 10.1093/ejo/19.2.131. [DOI] [PubMed] [Google Scholar]
  • 38.Rongen-Westerlaken C, vd Born E, Prahl-Andersen B, von Teunenbroek A, Manesse P, Otten BJ, vd Tweel I, Kuijpers-Jagtman AM, Delemarre vd Waa HA, Drayer NM. Effect of growth hormone treatment on craniofacial growth in Turner’s syndrome. Acta Paediatr. 1993;82(4):364–368. doi: 10.1111/j.1651-2227.1993.tb12698.x. [DOI] [PubMed] [Google Scholar]
  • 39.Zayed S, Madlon-Kay DJ. Growth hormone for treatment of idiopathic short stature in children. Am Fam Physician. 2015;92(1):64–64. [PubMed] [Google Scholar]
  • 40.Cook DM, Rose SR. A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary. 2012;15(3):301–310. doi: 10.1007/s11102-011-0372-6. [DOI] [PubMed] [Google Scholar]
  • 41.Bondy CA, Tuner Syndrome Study Group Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92(1):10–25. doi: 10.1210/jc.2006-1374. [DOI] [PubMed] [Google Scholar]
  • 42.Kjellberg H, Wikland KA. A longitudinal study of craniofacial growth in idiopathic short stature and growth hormonedeficient boys treated with growth hormone. Eur J Orthod. 2007;29(3):243–250. doi: 10.1093/ejo/cjm005. [DOI] [PubMed] [Google Scholar]
  • 43.Davidopoulou S, Chatzigianni A. Craniofacial morphology and dental maturity in children with reduced somatic growth of different aetiology and the effect of growth hormone treatment. Progress in Orthodontics. 2017;18(1):10–10. doi: 10.1186/s40510-017-0164-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Konfino R, Pertzelan A, Laron Z. Cephalometric measurements of familial dwarfism and high plasma immunoreactive growth hormone. Am J Orthod. 1975;68(2):196–201. doi: 10.1016/0002-9416(75)90208-0. [DOI] [PubMed] [Google Scholar]
  • 45.Salas-Flores R, González-Pérez B, Barajas-Campos RL, Gonzalez-Cruz B. Changes on craniofacial structures in children with growth-hormone-deficiency. Rev Med Inst Mex Seguro Soc. 2010;48(6):591–595. [PubMed] [Google Scholar]
  • 46.Ranke MB. Treatment of children and adolescents with idiopathic short stature. Nat Rev Endocrinol. 2013;9(6):325–334. doi: 10.1038/nrendo.2013.71. [DOI] [PubMed] [Google Scholar]
  • 47.Loche S, Carta L, Ibba A, Guzzetti C. Growth hormone treatment in non-growth hormone-deficient children. Ann Pediatr Endocrinol Metab. 2014;19(1):1–7. doi: 10.6065/apem.2014.19.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Hodge N, Evans CA, Simmons KE, Fadavi S, Viana G. Occlusal characteristics of individuals with growth hormone deficiency, idiopathic short stature, and Russell-Silver syndrome. J Dent Child (Chic) 2015;82(3):135–140. [PubMed] [Google Scholar]
  • 49.Ito RK, Vig KW, Garn SM, Hopwood NJ, Loos PJ, Spalding PM, Deputy BS, Hoard BC. The influence of growth hormone therapy on tooth formation in idiopathic short statured children. Am J Orthod Dentofac Orthop. 1993;103(4):358–364. doi: 10.1016/0889-5406(93)70017-I. [DOI] [PubMed] [Google Scholar]
  • 50.Krekmanova L, Carlstedt-Duke J, Bronnegard M, Marcus C, Grondahl E, Modeer T. Dental maturity in children of short stature with or without growth hormone deficiency. Eur J Oral Sci. 1997;105(6):551–556. doi: 10.1111/j.1600-0722.1997.tb00216.x. [DOI] [PubMed] [Google Scholar]
  • 51.Flores-Mir C, Mauricio FR, Orellana MF, Major PW. Association between growth stunting with dental age development and skeletal maturation stage. Angle Orthod. 2005;75(6):935–940. doi: 10.1043/0003-3219(2005)75[935:ABGSWD]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 52.Różyło-Kalinowska I, Kolasa-Rączka A, Kalinowski P. Relationship between dental age according to Demirjian and cervical vertebrae maturity in polish children. Eur J Orthod. 2011;33(1):75–83. doi: 10.1093/ejo/cjq031. [DOI] [PubMed] [Google Scholar]
  • 53.Davidopoulou S, Chatzigianni A. Craniofacial morphology and dental maturity in children with reduced somatic growth of different aetiology and the effect of growth hormone treatment. Progress in Orthodontics. 2017;18(1):10–10. doi: 10.1186/s40510-017-0164-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab. 2007;92(3):804–810. doi: 10.1210/jc.2006-2017. [DOI] [PubMed] [Google Scholar]

Articles from Current Health Sciences Journal are provided here courtesy of Editura Medicală Universitară

RESOURCES